Recent Company News

• 03:52 AM ET Jun 12, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (58 total)

• 04:15 AM ET Jun 10, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (62 total)

• 04:13 AM ET Jun 06, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (81 total)

• 03:58 AM ET Jun 04, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (83 total)

• 02:37 PM ET Jun 03, 2025
  

  Follow-up: FDA approves Nubeqa (darolutamide) for mCSPC (€24.96, 0.00)

• 02:30 PM ET Jun 03, 2025
  

  FDA approves Nubeqa (darolutamide) for mCSPC (€24.96, 0.00)

• 08:04 AM ET May 27, 2025
  

  Bayer announces new phase iii ARANOTE post-hoc analyses on health-related quality of life and pain outcomes in patients with metastatic castration-sensitive prostate cancer receiving NUBEQA (darolutamide) plus ADT presented at 2025 ASCO (€24.85, +0.17)

• 05:40 AM ET May 23, 2025
  

  Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market (€58.50, -0.40)

• 03:31 AM ET May 22, 2025
  

  Orion releases presentation material in connection with its CMD (€59.50, -0.25)

• 04:20 AM ET May 21, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning